# The Effect of Central Sensitization on Treatment Response in Patients With Fibromyalgia

> **NCT05020600** · — · UNKNOWN · sponsor: **Marmara University** · enrollment: 40 (estimated)

## Conditions studied

- Central Sensitisation
- Fibromyalgia

## Interventions

- **DRUG:** Duloxetine
- **DRUG:** Pregabalin
- **DRUG:** Amitriptyline

## Key facts

- **NCT ID:** NCT05020600
- **Lead sponsor:** Marmara University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-19
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05020600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05020600, "The Effect of Central Sensitization on Treatment Response in Patients With Fibromyalgia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05020600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*